12/19
02:06 am
valn
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India [Yahoo! Finance]
High
Report
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India [Yahoo! Finance]
12/19
02:00 am
valn
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India
High
Report
Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India
12/4
01:05 am
valn
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal [Yahoo! Finance]
Medium
Report
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal [Yahoo! Finance]
12/4
01:00 am
valn
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Medium
Report
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
12/3
01:07 am
valn
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® [Yahoo! Finance]
Low
Report
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® [Yahoo! Finance]
12/3
01:00 am
valn
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®
Low
Report
Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®
11/28
11:38 am
valn
Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock [Yahoo! Finance]
Low
Report
Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock [Yahoo! Finance]
11/26
11:45 am
valn
Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
Neutral
Report
Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
12/19
06:05 am
valn
Form 6-K Valneva SE For: Dec 19
High
Report
Form 6-K Valneva SE For: Dec 19
12/4
12:00 pm
valn
Form 6-K Valneva SE For: Dec 04
Medium
Report
Form 6-K Valneva SE For: Dec 04
12/3
07:30 am
valn
Form 6-K Valneva SE For: Dec 03
Low
Report
Form 6-K Valneva SE For: Dec 03
11/26
05:05 pm
valn
Form 6-K Valneva SE For: Nov 26
Low
Report
Form 6-K Valneva SE For: Nov 26
11/13
02:19 pm
valn
Form 6-K Valneva SE For: Nov 13
Medium
Report
Form 6-K Valneva SE For: Nov 13
11/7
10:32 am
valn
Form 6-K Valneva SE For: Sep 30
Low
Report
Form 6-K Valneva SE For: Sep 30
10/21
04:05 pm
valn
Form 6-K Valneva SE For: Oct 21
Low
Report
Form 6-K Valneva SE For: Oct 21
10/16
03:47 pm
valn
Form 6-K Valneva SE For: Oct 16
Low
Report
Form 6-K Valneva SE For: Oct 16
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register